Hematology Oncology Services of Arkansas HOSA 2

Little Rock, Arkansas 72205

0 studies enrolling now · 1 studies all time

What they study most

High Risk MDS

Studies at this site

• Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox. — Stopped early